2007 Partners & Sponsors
The EPDA gratefully acknowledges the partnerships of the following companies who support our work programme.
Partnership Levels
Partnership levels recognise the contribution* and commitment that our partners and sponsors make to the EPDA.
- Platinum Partners
Corporations that make commitment in kind and/or cash valued at 25,000 Euro or more a year
- Gold Partner
Corporations that make a commitment in kind and/or cash valued between 15,000 and 25,000 Euro a year
- Silver Partner
Corporations that make a commitment in kind and/or cash valued between 5,000 and 15,000 Euro a year
- Bronze Partner
Corporations that make a commitment in kind and/or cash valued between 1,000 and 5,000 Euro a year
*
The level of partnership is determined by the amount of core funding, financial support for individual projects and resources provided. This level can change throughout the year should project involvement be increased.
Project Sponsors
Sponsors provide donations and /or contributions to specific projects.
Partnership Funding
| Platinum |
Gold |
Silver |
Britannia Pharmaceuticals
€7,500 |
F. Hoffmann-La Roche Ltd.
€15,888 |
Boehringer Ingleheim
€7,500 |
GE Healthcare
€27,350 |
|
H Lundbeck
€5,000 |
GlaxoSmithKline
€39,800 |
|
Norgine
€7,500 |
Medtronic
€16,000 |
|
Schwarz Pharma
€6,000 |
Novartis A/G
€12,500 |
|
Teva Pharmaceuticals
€5,000 |
Orion Pharma
€12,500 |
|
Valeant Pharmaceuticals
€7,000 |
Solvay Pharmaceuticals
€20,000 |
|
|